Position in VRTX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$393,848
+$15,293 QoQ
Shares Held
882
+5.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HBK Sorce Advisory LLC holds $7,101,603 across 9 Biotechnology names. VRTX ranks #2 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAPR |
Capricor Therapeutics, Inc.
|
204,837 | $6,227,044 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
882 | $393,848 | |
| 3 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
11,167 | $276,494 | |
| 4 | ABCL |
AbCellera Biologics Inc.
|
26,183 | $91,378 | |
| 5 | DTIL |
Precision Biosciences Inc
|
10,164 | $55,902 | |
| 6 | CRBU |
Caribou Biosciences, Inc.
|
12,344 | $23,453 | |
| 7 | LXRX |
Lexicon Pharmaceuticals, Inc.
|
11,786 | $18,386 | |
| 8 | HOWL |
Werewolf Therapeutics, Inc.
|
13,227 | $11,018 |
All Filings in VRTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $393,848 | 882 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $378,555 | 835 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $260,048 | 664 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $307,188 | 690 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $287,983 | 594 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $226,720 | 563 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $246,957 | 531 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $239,984 | 512 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||